{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:11:48Z","timestamp":1775837508667,"version":"3.50.1"},"reference-count":110,"publisher":"IOP Publishing","issue":"5","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Mater."],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Glioblastoma (GBM) is the most aggressive and lethal malignant brain tumor, and it is challenging to cure with surgery and treatment. The prevention of permanent brain damage and tumor invasion, which is the ultimate cause of recurrence, are major obstacles in GBM treatment. Besides, emerging treatment modalities and newer genetic findings are helping to understand and manage GBM in patients. Accordingly, researchers are focusing on advanced nanomaterials-based strategies for tackling the various problems associated with GBM. In this context, researchers explored novel strategies with various alternative treatment approaches such as early detection techniques and theranostics approaches. In this review, we have emphasized the recent advancement of GBM cellular models and their roles in designing GBM therapeutics. We have added a special emphasis on the novel genetic and drug target findings as well as strategies for early detection. Besides, we have discussed various theranostic approaches such as hyperthermia therapy, phototherapy and image-guided therapy. Approaches utilized for targeted drug delivery to the GBM were also discussed. This article also describes the recent <jats:italic>in vivo, in vitro<\/jats:italic> and <jats:italic>ex vivo<\/jats:italic> advances using innovative theranostic approaches.<\/jats:p>","DOI":"10.1088\/1748-605x\/acf0ab","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T18:49:37Z","timestamp":1692125377000},"page":"052007","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Recent advancements and theranostics strategies in glioblastoma therapy"],"prefix":"10.1088","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4142-6625","authenticated-orcid":true,"given":"Sudhakar Reddy","family":"Baddam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhakar","family":"Kalagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Kuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivas","family":"Enaganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"bmmacf0abbib1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc1889","type":"journal-article","article-title":"Brain tumour stem cells","volume":"6","author":"Vescovi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"bmmacf0abbib2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3892\/mco.2013.172","type":"journal-article","article-title":"Glioma and glioblastoma how much do we (not) know?","volume":"1","author":"Jov\u010devska","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"bmmacf0abbib3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.22034\/APJCP.2017.18.1.3","type":"journal-article","article-title":"Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"bmmacf0abbib4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","type":"journal-article","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"bmmacf0abbib5","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","type":"journal-article","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-oncology"},{"key":"bmmacf0abbib6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-021-01020-2","type":"journal-article","article-title":"Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors","volume":"23","author":"Overcast","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"bmmacf0abbib7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jmoldx.2013.05.011","type":"journal-article","article-title":"The role of MGMT testing in clinical practice: a report of the association for molecular pathology","volume":"15","author":"Cankovic","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"bmmacf0abbib8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/jnnp-2020-325334","type":"journal-article","article-title":"Advances in the management of glioblastoma","volume":"92","author":"Ma","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"bmmacf0abbib9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11060-020-03598-2","type":"journal-article","article-title":"Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor","volume":"151","author":"Hotchkiss","year":"2021","journal-title":"J. Neurooncol."},{"key":"bmmacf0abbib10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106308","type":"journal-article","article-title":"Integrative multi-omics approach to targeted therapy for glioblastoma","volume":"182","author":"Koh","year":"2022","journal-title":"Pharmacol. Res. Commun."},{"key":"bmmacf0abbib11","doi-asserted-by":"publisher","first-page":"e6501","DOI":"10.1002\/cpe.6501","type":"journal-article","article-title":"Brain tumor segmentation and overall survival period prediction in glioblastoma multiforme using radiomic features","volume":"34","author":"Das","year":"2022","journal-title":"Concurr. Comput."},{"key":"bmmacf0abbib12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jconrel.2021.07.031","type":"journal-article","article-title":"Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review","volume":"337","author":"Bastiancich","year":"2021","journal-title":"J. Control. Release"},{"key":"bmmacf0abbib13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14737159.2022.2019016","type":"journal-article","article-title":"Brain tumors and circulating microRNAs: a systematic review and diagnostic meta-analysis","volume":"22","author":"Aalami","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"key":"bmmacf0abbib14","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1111\/ene.15391","type":"journal-article","article-title":"The European Academy of Neurology Brain Health Strategy: one brain, one life, one approach","volume":"29","author":"Bassetti","year":"2022","journal-title":"Eur. Neurol."},{"key":"bmmacf0abbib15","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105857","type":"journal-article","article-title":"A new brain tumor diagnostic model: selection of textural feature extraction algorithms and convolution neural network features with optimization algorithms","volume":"148","author":"Ba\u015faran","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"bmmacf0abbib16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28803","type":"journal-article","article-title":"A case of glioblastoma, isocitrate dehydrogenase wild type, with widely disseminated osseous metastasis","volume":"14","author":"Conte","year":"2022","journal-title":"Cureus"},{"key":"bmmacf0abbib17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","type":"journal-article","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"key":"bmmacf0abbib18","article-title":"Gliomas","author":"Mesfin","year":"2023","type":"other"},{"key":"bmmacf0abbib19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2022.104006","type":"journal-article","article-title":"Deep neural networks for neuro-oncology: towards patient individualized design of chemo-radiation therapy for glioblastoma patients","volume":"127","author":"Zade","year":"2022","journal-title":"J. Biomed. Inform."},{"key":"bmmacf0abbib20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-030-87308-0","type":"book","article-title":"Central nervous system tumors","author":"Beyzadeoglu","year":"2022"},{"key":"bmmacf0abbib21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.884158","type":"journal-article","article-title":"Carmustine wafers implantation in patients with newly diagnosed high grade glioma: is it still an option?","volume":"13","author":"Ricciardi","year":"2022","journal-title":"Front. Neurol."},{"key":"bmmacf0abbib22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/cancers11020174","type":"journal-article","article-title":"Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review","volume":"11","author":"Fabian","year":"2019","journal-title":"Cancers"},{"key":"bmmacf0abbib23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/1120009X.2020.1713508","type":"journal-article","article-title":"Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology","volume":"32","author":"Rezaei","year":"2020","journal-title":"J. Chemother."},{"key":"bmmacf0abbib24","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.3390\/polym13234114","type":"journal-article","article-title":"Development of polymer-based nanoformulations for glioblastoma brain cancer therapy and diagnosis: an update","volume":"13","author":"Rabha","year":"2021","journal-title":"Polymers"},{"key":"bmmacf0abbib25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/ma12101588","type":"journal-article","article-title":"Nanotechnology meets oncology: nanomaterials in brain cancer research, diagnosis and therapy","volume":"12","author":"Zottel","year":"2019","journal-title":"Materials"},{"key":"bmmacf0abbib26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/pr.117.014944","type":"journal-article","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"bmmacf0abbib27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","type":"journal-article","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"bmmacf0abbib28","first-page":"131","author":"Kijima","year":"2017","type":"book"},{"key":"bmmacf0abbib29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188458","type":"journal-article","article-title":"Pre-clinical tumor models of primary brain tumors: challenges and opportunities","volume":"1875","author":"Akter","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"bmmacf0abbib30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ijms19010294","type":"journal-article","article-title":"Telomeres: implications for cancer development","volume":"19","author":"Bernal","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"bmmacf0abbib31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/neuonc\/nos135","type":"journal-article","article-title":"In vivo models of primary brain tumors: pitfalls and perspectives","volume":"14","author":"Huszthy","year":"2012","journal-title":"Neuro-oncology"},{"key":"bmmacf0abbib32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nn.3019","type":"journal-article","article-title":"Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas","volume":"15","author":"Kauer","year":"2012","journal-title":"Nat. Neurosci."},{"key":"bmmacf0abbib33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","type":"journal-article","article-title":"Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens","volume":"4","author":"Pollard","year":"2009","journal-title":"Cell Stem Cell"},{"key":"bmmacf0abbib34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/neuonc\/noy192","type":"journal-article","article-title":"Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma","volume":"21","author":"Grommes","year":"2019","journal-title":"Neuro-oncology"},{"key":"bmmacf0abbib35","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.3390\/ijms21093162","type":"journal-article","article-title":"Investigating programmed cell death and tumor invasion in a three-dimensional (3D) microfluidic model of glioblastoma","volume":"21","author":"Samiei","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"bmmacf0abbib36","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.09.434656v2.full)","type":"other","article-title":"Structural connectome quantifies tumor invasion and predicts survival in glioblastoma patients","author":"Wei","year":"2021"},{"key":"bmmacf0abbib37","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3390\/cancers13102449","type":"journal-article","article-title":"In vitro glioblastoma models: a journey into the third dimension","volume":"13","author":"Paolillo","year":"2021","journal-title":"Cancers"},{"key":"bmmacf0abbib38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.604121","type":"journal-article","article-title":"Glioblastoma organoids: pre-clinical applications and challenges in the context of immunotherapy","volume":"10","author":"Klein","year":"2020","journal-title":"Front. Oncol."},{"key":"bmmacf0abbib39","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nprot.2012.051","type":"journal-article","article-title":"Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels","volume":"7","author":"Shin","year":"2012","journal-title":"Nat. Protocols"},{"key":"bmmacf0abbib40","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00401-020-02226-7","type":"journal-article","article-title":"Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology","volume":"140","author":"Golebiewska","year":"2020","journal-title":"Acta Neuropathol."},{"key":"bmmacf0abbib41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semcancer.2021.02.014","type":"journal-article","article-title":"Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors","volume":"82","author":"Lauko","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"bmmacf0abbib42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1515\/folmed-2017-0069","type":"journal-article","article-title":"On the concepts and history of glioblastoma multiforme\u2014morphology, genetics and epigenetics","volume":"60","author":"Stoyanov","year":"2018","journal-title":"Folia Med."},{"key":"bmmacf0abbib43","first-page":"125","type":"journal-article","article-title":"Glioblastoma genetics: in rapid flux","volume":"9","author":"Purow","year":"2010","journal-title":"Discov. Med."},{"key":"bmmacf0abbib44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/labinvest.2016.142","type":"journal-article","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru","year":"2017","journal-title":"Lab. Invest."},{"key":"bmmacf0abbib45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103288","type":"journal-article","article-title":"Nano-immunotherapeutic strategies for targeted RNA delivery: emphasizing the role of monocyte\/macrophages as nanovehicles to treat glioblastoma multiforme","volume":"71","author":"Manicum","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"bmmacf0abbib46","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","type":"journal-article","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"bmmacf0abbib47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12974-020-01797-2","type":"journal-article","article-title":"Glioblastoma hijacks microglial gene expression to support tumor growth","volume":"17","author":"Maas","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"bmmacf0abbib48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-020-02085-1","type":"journal-article","article-title":"Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance","volume":"21","author":"Eyler","year":"2020","journal-title":"Genome Biol."},{"key":"bmmacf0abbib49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/biom9050201","type":"journal-article","article-title":"Identification of crucial candidate genes and pathways in glioblastoma multiform by bioinformatics analysis","volume":"9","author":"Alshabi","year":"2019","journal-title":"Biomolecules"},{"key":"bmmacf0abbib50","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/jnen\/nly085","type":"journal-article","article-title":"A revised diagnostic classification of canine glioma: towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma","volume":"77","author":"Koehler","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"bmmacf0abbib51","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.040386","type":"journal-article","article-title":"Experimental models and tools to tackle glioblastoma","volume":"12","author":"Robertson","year":"2019","journal-title":"Dis. Models Mech."},{"key":"bmmacf0abbib52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molmed.2008.03.003","type":"journal-article","article-title":"Cell- and peptide-based immunotherapeutic approaches for glioma","volume":"14","author":"Yamanaka","year":"2008","journal-title":"Trends Mol. Med."},{"key":"bmmacf0abbib53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nec.2009.09.001","type":"journal-article","article-title":"Clinical applications of a peptide-based vaccine for glioblastoma","volume":"21","author":"Kanaly","year":"2010","journal-title":"Neurosurg. Clin. North Am."},{"key":"bmmacf0abbib54","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2217\/imt.14.21","type":"journal-article","article-title":"Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme","volume":"6","author":"Swartz","year":"2014","journal-title":"Immunotherapy"},{"key":"bmmacf0abbib55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603911","type":"journal-article","article-title":"Current immunotherapies for glioblastoma multiforme","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"bmmacf0abbib56","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1158\/1078-0432.CCR-16-0506","type":"journal-article","article-title":"A cancer research UK first time in human phase I trial of IMA950 (novel multipeptide therapeutic vaccine) in patients with newly diagnosed glioblastoma IMA950 phase I trial final results","volume":"22","author":"Rampling","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"bmmacf0abbib57","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1158\/1078-0432.CCR-09-0715","type":"journal-article","article-title":"IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas","volume":"15","author":"Nobusawa","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"bmmacf0abbib58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-013-0345-4","type":"journal-article","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"13","author":"Cohen","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"bmmacf0abbib59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.12.010","type":"journal-article","article-title":"Resistance to checkpoint inhibition in cancer immunotherapy","volume":"13","author":"Barrueto","year":"2020","journal-title":"Transl. Oncol."},{"key":"bmmacf0abbib60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11523-019-00655-3","type":"journal-article","article-title":"The role of checkpoint inhibitors in glioblastoma","volume":"14","author":"Desai","year":"2019","journal-title":"Target. Oncol."},{"key":"bmmacf0abbib61","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1210\/en.2011-1579","type":"journal-article","article-title":"Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes","volume":"153","author":"Kanzaki","year":"2012","journal-title":"Endocrinology"},{"key":"bmmacf0abbib62","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","type":"journal-article","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"bmmacf0abbib63","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1200\/JCO.2013.50.4423","type":"journal-article","article-title":"Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma","volume":"32","author":"Navid","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"bmmacf0abbib64","doi-asserted-by":"publisher","first-page":"220","DOI":"10.7861\/clinmedicine.17-3-220","type":"journal-article","article-title":"Developments in therapy with monoclonal antibodies and related proteins","volume":"17","author":"Shepard","year":"2017","journal-title":"Clin. Med."},{"key":"bmmacf0abbib65","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.2147\/OTT.S124008","type":"journal-article","article-title":"Targeting the PD-1 pathway in pediatric solid tumors and brain tumors","volume":"10","author":"Wagner","year":"2017","journal-title":"OncoTargets Ther."},{"key":"bmmacf0abbib66","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3171\/2017.3.JNS162280","type":"journal-article","article-title":"Detection of glioblastoma in biofluids","volume":"129","author":"Figueroa","year":"2018","journal-title":"J. Neurosurg."},{"key":"bmmacf0abbib67","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/PPO.0000000000000541","type":"journal-article","article-title":"Circulating biomarkers in glioblastoma: ready for prime time?","volume":"27","author":"Mathios","year":"2021","journal-title":"Cancer J."},{"key":"bmmacf0abbib68","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3892\/ijo.2014.2459","type":"journal-article","article-title":"miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients","volume":"45","author":"Dong","year":"2014","journal-title":"Int. J. Oncol."},{"key":"bmmacf0abbib69","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/cells8080863","type":"journal-article","article-title":"Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics","volume":"8","author":"Silantyev","year":"2019","journal-title":"Cells"},{"key":"bmmacf0abbib70","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.3390\/ijms21207522","type":"journal-article","article-title":"Novel molecular markers in glioblastoma\u2014benefits of liquid biopsy","volume":"21","author":"Birk\u00f3","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"bmmacf0abbib71","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/2019.9.FOCUS19613","type":"journal-article","article-title":"Vascular architecture mapping for early detection of glioblastoma recurrence","volume":"47","author":"Stadlbauer","year":"2019","journal-title":"Neurosurg. Focus"},{"key":"bmmacf0abbib72","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.3390\/molecules26195992","type":"journal-article","article-title":"Longitudinal bottom-up proteomics of serum, serum extracellular vesicles, and cerebrospinal fluid reveals candidate biomarkers for early detection of glioblastoma in a murine model","volume":"26","author":"Greco","year":"2021","journal-title":"Molecules"},{"key":"bmmacf0abbib73","doi-asserted-by":"publisher","first-page":"e1575","DOI":"10.1002\/wnan.1575","type":"journal-article","article-title":"Immunoengineering in glioblastoma imaging and therapy","volume":"11","author":"Zanganeh","year":"2019","journal-title":"Wiley Interdiscip. Rev.: Nanomed."},{"key":"bmmacf0abbib74","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1166\/jbn.2016.2173","type":"journal-article","article-title":"Theranostic application of mixed gold and superparamagnetic iron oxide nanoparticle micelles in glioblastoma multiforme","volume":"12","author":"Sun","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"bmmacf0abbib75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119783","type":"journal-article","article-title":"Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma","volume":"235","author":"Shen","year":"2020","journal-title":"Biomaterials"},{"key":"bmmacf0abbib76","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13346-020-00880-8","type":"journal-article","article-title":"SPION and doxorubicin-loaded polymeric nanocarriers for glioblastoma theranostics","volume":"11","author":"Luque-Michel","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"bmmacf0abbib77","doi-asserted-by":"publisher","first-page":"26759","DOI":"10.1021\/acsami.1c04990","type":"journal-article","article-title":"An advanced in situ magnetic resonance imaging and ultrasonic theranostics nanocomposite platform: crossing the blood\u2013brain barrier and improving the suppression of glioblastoma using iron-platinum nanoparticles in nanobubbles","volume":"13","author":"Chan","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"bmmacf0abbib78","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ab2164","type":"journal-article","article-title":"Slowdown intracranial glioma progression by optical hyperthermia therapy: study on a CT-2A mouse astrocytoma model","volume":"30","author":"Casanova-Carvajal","year":"2019","journal-title":"Nanotechnology"},{"key":"bmmacf0abbib79","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1021\/acs.bioconjchem.1c00321","type":"journal-article","article-title":"Dual blood\u2013brain barrier\u2013glioma targeting peptide\u2013poly (levodopamine) hybrid nanoplatforms as potential near infrared phototheranostic agents in glioblastoma","volume":"32","author":"Dube","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"bmmacf0abbib80","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203120","type":"journal-article","article-title":"A novel patient\u2010personalized nanovector based on homotypic recognition and magnetic hyperthermia for an efficient treatment of glioblastoma multiforme","volume":"12","author":"De Pasquale","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"bmmacf0abbib81","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/10407782.2022.2102404","type":"journal-article","article-title":"Evaluation of the glioblastoma multiforme treatment with hyperthermia using the finite element method","volume":"83","author":"Sa\u011f\u0131ro\u011flu","year":"2023","journal-title":"Numer. Heat Transfer A"},{"key":"bmmacf0abbib82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2022.05.032.","type":"journal-article","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"bmmacf0abbib83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1021\/acs.langmuir.1c02500","type":"journal-article","article-title":"Membrane-decorated exosomes for combination drug delivery and improved glioma therapy","volume":"38","author":"Liang","year":"2022","journal-title":"Langmuir"},{"key":"bmmacf0abbib84","doi-asserted-by":"publisher","first-page":"33637","DOI":"10.1021\/acsami.9b10787","type":"journal-article","article-title":"Systematic evaluation of transferrin-modified porous silicon nanoparticles for targeted delivery of doxorubicin to glioblastoma","volume":"11","author":"Luo","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"bmmacf0abbib85","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1021\/acsbiomaterials.0c00094","type":"journal-article","article-title":"Macroscopic silicone microchannel matrix for tailored drug release and localized glioblastoma therapy","volume":"6","author":"Rasch","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"bmmacf0abbib86","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1021\/acsami.0c04102","type":"journal-article","article-title":"Tumor responsive and tunable polymeric platform for optimized delivery of paclitaxel to treat glioblastoma","volume":"12","author":"Graham-Gurysh","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"bmmacf0abbib87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121563","type":"journal-article","article-title":"Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo","volume":"616","author":"Bruinsmann","year":"2022","journal-title":"Int. J. Pharm."},{"key":"bmmacf0abbib88","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102581","type":"journal-article","article-title":"Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment","volume":"44","author":"Ye","year":"2022","journal-title":"Nanomedicine"},{"key":"bmmacf0abbib89","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112463","type":"journal-article","article-title":"Bimetallic gold-platinum nanoparticles as a drug delivery system coated with a new drug to target glioblastoma.","volume":"214","author":"Stavropoulou","year":"2022","journal-title":"Colloids Surf. B"},{"key":"bmmacf0abbib90","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1021\/mp3002733","type":"journal-article","article-title":"RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharm."},{"key":"bmmacf0abbib91","doi-asserted-by":"publisher","first-page":"fmvii","DOI":"10.1002\/ajmg.a.33182","type":"journal-article","article-title":"The AJMG SEQUENCE: decoding news and trends for the medical genetics community","volume":"149A","author":"Levenson","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"bmmacf0abbib92","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13311-018-00702-3","type":"journal-article","article-title":"Oligonucleotide therapeutics as a new class of drugs for malignant brain tumors: targeting mRNAs, regulatory RNAs, mutations, combinations, and beyond","volume":"16","author":"Krichevsky","year":"2019","journal-title":"Neurotherapeutics"},{"key":"bmmacf0abbib93","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acs.molpharmaceut.0c00911","type":"journal-article","article-title":"Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting","volume":"18","author":"Wang","year":"2021","journal-title":"Mol. Pharm."},{"key":"bmmacf0abbib94","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10426","type":"journal-article","article-title":"Brain\u2010targeted exosome\u2010mimetic cell membrane nanovesicles with therapeutic oligonucleotides elicit anti\u2010tumor effects in glioblastoma animal models","volume":"8","author":"Lee","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"bmmacf0abbib95","doi-asserted-by":"publisher","first-page":"667","DOI":"10.18632\/oncotarget.28039","type":"book","article-title":"Role of microRNA therapy in presensitizing glioblastoma cells to temozolomide treatment","author":"Paulmurugan","year":"2021"},{"key":"bmmacf0abbib96","doi-asserted-by":"publisher","first-page":"eadd8280","DOI":"10.1126\/scitranslmed.add8280","type":"journal-article","article-title":"Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma","volume":"15","author":"Zhang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"bmmacf0abbib97","doi-asserted-by":"publisher","first-page":"S2090","DOI":"10.1016\/j.jare.2023.01.005","type":"journal-article","article-title":"Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models","volume":"23","author":"Lee","year":"2023","journal-title":"J. Adv. Res."},{"key":"bmmacf0abbib98","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.37285\/ijpsn.2010.3.3.2","type":"journal-article","article-title":"Current trends of nanotechnology for cancer therapy","volume":"3","author":"Anajwala","year":"2010","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"key":"bmmacf0abbib99","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41565-019-0589-5","type":"journal-article","article-title":"Nanotechnology intervention of the microbiome for cancer therapy","volume":"14","author":"Song","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"bmmacf0abbib100","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","type":"journal-article","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"bmmacf0abbib101","doi-asserted-by":"publisher","first-page":"138","DOI":"10.22270\/jddt.v3i4.541","type":"journal-article","article-title":"Nanoparticles & nanotechnology: clinical, toxicological, social, regulatory & other aspects of nanotechnology","volume":"3","author":"Chakarvarty","year":"2013","journal-title":"J. Drug Deliv. Ther."},{"key":"bmmacf0abbib102","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.aaf.2021.12.006","type":"journal-article","article-title":"Nanotechnology in aquaculture: applications, perspectives and regulatory challenges","volume":"7","author":"Fajardo","year":"2022","journal-title":"Aquac. Fish."},{"key":"bmmacf0abbib103","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2018.05.008","type":"journal-article","article-title":"Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment","volume":"281","author":"Ganipineni","year":"2018","journal-title":"J. Control. Release"},{"key":"bmmacf0abbib104","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2014.10.06","type":"journal-article","article-title":"Advances and challenges in the molecular biology and treatment of glioblastoma\u2014is there any hope for the future?","volume":"3","author":"Veliz","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"bmmacf0abbib105","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/ijms23031711","type":"journal-article","article-title":"Delivering therapeutics to glioblastoma: overcoming biological constraints","volume":"23","author":"Mathew","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"bmmacf0abbib106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/2152-7806.132138","type":"journal-article","article-title":"Glioblastoma multiforme: state of the art and future therapeutics","volume":"5","author":"Wilson","year":"2014","journal-title":"Surg. Neurol. Int."},{"key":"bmmacf0abbib107","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jconrel.2020.09.002","type":"journal-article","article-title":"Advances in drug delivery technology for the treatment of glioblastoma multiforme","volume":"328","author":"Cha","year":"2020","journal-title":"J. Control. Release"},{"key":"bmmacf0abbib108","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/pharmaceutics14020456","type":"journal-article","article-title":"Progress and viewpoints of multifunctional composite nanomaterials for glioblastoma theranostics","volume":"14","author":"Chan","year":"2022","journal-title":"Pharmaceutics"},{"key":"bmmacf0abbib109","doi-asserted-by":"publisher","first-page":"rbab062","DOI":"10.1093\/rb\/rbab062","type":"journal-article","article-title":"Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics","volume":"8","author":"Wu","year":"2021","journal-title":"Regen. Biomater."},{"key":"bmmacf0abbib110","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/ijms23031641","type":"journal-article","article-title":"Modernistic and emerging developments of nanotechnology in glioblastoma-targeted theranostic applications","volume":"23","author":"Lakshmi","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedical Materials"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:49:29Z","timestamp":1760186969000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/acf0ab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":110,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,8,24]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1748-605x\/acf0ab","relation":{},"ISSN":["1748-6041","1748-605X"],"issn-type":[{"value":"1748-6041","type":"print"},{"value":"1748-605X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"Recent advancements and theranostics strategies in glioblastoma therapy","name":"article_title","label":"Article Title"},{"value":"Biomedical Materials","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2023 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2023-04-23","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2023-08-15","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2023-08-24","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}